| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
22,779 |
18,636 |
$31K |
| 99214 |
|
8,270 |
7,088 |
$11K |
| 90834 |
|
10,406 |
6,573 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
271 |
244 |
$3K |
| 90837 |
|
1,846 |
1,271 |
$3K |
| 90832 |
|
4,200 |
2,880 |
$2K |
| 99417 |
Prolong home eval add 15m |
3,247 |
2,760 |
$1K |
| 99395 |
|
419 |
384 |
$696.91 |
| 90833 |
|
1,210 |
978 |
$538.73 |
| 97803 |
|
1,151 |
1,112 |
$522.25 |
| 0003A |
|
12 |
12 |
$400.00 |
| 91312 |
|
21 |
12 |
$320.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
45 |
43 |
$291.67 |
| 91320 |
|
399 |
295 |
$240.00 |
| 0124A |
|
48 |
27 |
$220.72 |
| 82306 |
|
875 |
813 |
$201.85 |
| 90471 |
|
1,488 |
1,402 |
$168.04 |
| 84443 |
|
582 |
551 |
$137.46 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
26 |
25 |
$130.50 |
| 99213 |
|
54 |
43 |
$115.00 |
| 80061 |
|
842 |
782 |
$94.85 |
| 83036 |
|
1,152 |
1,087 |
$79.38 |
| 97530 |
|
2,352 |
1,079 |
$67.10 |
| 90480 |
|
342 |
303 |
$54.10 |
| 90686 |
|
707 |
667 |
$47.31 |
| 80053 |
|
950 |
882 |
$44.95 |
| 90472 |
|
94 |
60 |
$41.44 |
| 85025 |
|
667 |
615 |
$39.96 |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
1,063 |
834 |
$32.60 |
| 90656 |
|
149 |
148 |
$22.35 |
| 82746 |
|
16 |
15 |
$20.65 |
| 82607 |
|
16 |
15 |
$20.55 |
| 96372 |
|
198 |
176 |
$10.45 |
| 36415 |
|
1,228 |
1,134 |
$3.70 |
| G0008 |
Administration of influenza virus vaccine |
30 |
30 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
21 |
17 |
$0.00 |
| 80050 |
|
80 |
74 |
$0.00 |
| 90688 |
|
245 |
230 |
$0.00 |
| 92609 |
|
19 |
12 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
83 |
54 |
$0.00 |
| 84439 |
|
91 |
82 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
281 |
245 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
326 |
237 |
$0.00 |
| 69210 |
|
33 |
29 |
$0.00 |
| 99354 |
|
18 |
14 |
$0.00 |